Listen on the go
CORRECT!
Next question
touchNEUROLOGY touchNEUROLOGY

Start Learning

Touch Loading image
JOURNALS
Start Learning
A Review of Hyaluronidase-facilitated Subcutaneous Immunoglobulin 10% as Maintenance Therapy for Chronic Inflammatory Demyelinating Polyradiculoneuropathy
JOURNALS
Start Learning
Making Connections: ACTRIMS Forum 2025 highlights key advances in MS research
JOURNALS
Start Learning
New McDonald criteria elevate role of biomarkers in MS diagnosis
touchMEETING HIGHLIGHTS
Start Learning
Dissecting Drivers of Disability: A Scientific Exploration of the Central Nervous System Immune Microenvironment in Multiple Sclerosis
Sponsored content
touchROUNDTABLE
Start Learning
Integrating the ALS genetic counseling and testing guidelines: considerations for your practice
Sponsored content
JOURNALS
Start Learning
Driving awareness and action with Parkinson’s Europe in 2025
JOURNALS
Start Learning
A new era in early Alzheimer’s diagnosis? The power of plasma biomarkers
JOURNALS
Start Learning
David Hafler: Motivations to milestones in multiple sclerosis
journal placeholder
JOURNALS
Start Learning
Prof. Konstantin Slavin leads the future of neuromodulation as new INS President
JOURNALS
Start Learning
Shaping the future of neurodiagnostics with Bedia Samanci: touchNEUROLOGY Future Leader 2025

to view Favourites, Keep Notes and Track CME Credits

Favourites
Shaping the future of MS care with Dr Bardia Nourbakhsh: touchNEUROLOGY Future Leader 2025
View
David Hafler: Motivations to milestones in multiple sclerosis
View
Motor gains achieved by 83% of paediatric SMA patients treated with onasemnogene abeparvovec
View
Shaping the future of neurodiagnostics with Bedia Samanci: touchNEUROLOGY Future Leader 2025
View
New study reveals Alzheimer’s disease progresses in two distinct phases
View
First diagnostic blood test for early Alzheimer’s disease cleared by FDA
View
Perspectives on psychiatric care with Dr Anna Laure: touchNEUROLOGY Future Leader 2025
View
Past Successes & Future Innovations in MS: Taking on Disability Accumulation Through Personalised Care, Biomarkers, and Clinical Trial Design
View
SOD1-ALS from Gene Discovery to Targeted Therapeutics: A Comprehensive Review
View
Dr Amit Bar-Or receives prestigious 2025 John Dystel Prize for MS Research
View
Copied to clipboard!
accredited arrow-down-editablearrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greenarrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-red tick-whiteticktimetranscriptup-arrowwebinar Sponsored Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72
Close Popup